129 related articles for article (PubMed ID: 15140130)
21. A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.
Riedelová-Reicheltová Z; Kotlín R; Suttnar J; Geierová V; Riedel T; Májek P; Dyr JE
Thromb Haemost; 2014 Jan; 111(1):79-87. PubMed ID: 24108601
[TBL] [Abstract][Full Text] [Related]
22. Impact of γ'γ' fibrinogen interaction with red blood cells on fibrin clots.
Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Sabban A; Martins IC; Duval C; Santos NC; Ariëns RA
Nanomedicine (Lond); 2018 Oct; 13(19):2491-2505. PubMed ID: 30311540
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.
Standeven KF; Grant PJ; Carter AM; Scheiner T; Weisel JW; Ariëns RA
Circulation; 2003 May; 107(18):2326-30. PubMed ID: 12707238
[TBL] [Abstract][Full Text] [Related]
24. Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability.
Flood VH; Nagaswami C; Chernysh IN; Al-Mondhiry HA; Weisel JW; Farrell DH
Br J Haematol; 2007 Jul; 138(1):117-24. PubMed ID: 17555455
[TBL] [Abstract][Full Text] [Related]
25. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
Weisel JW; Veklich Y; Gorkun O
J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
[TBL] [Abstract][Full Text] [Related]
26. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
Kamijyo Y; Hirota-Kawadobora M; Yamauchi K; Terasawa F; Honda T; Ikeya M; Okumura N
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
[TBL] [Abstract][Full Text] [Related]
27. Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization.
Homer VM; Mullin JL; Brennan SO; Barr A; George PM
J Thromb Haemost; 2003 Jun; 1(6):1245-50. PubMed ID: 12871326
[TBL] [Abstract][Full Text] [Related]
28. Role of the alpha C domains of fibrin in clot formation.
Gorkun OV; Veklich YI; Medved LV; Henschen AH; Weisel JW
Biochemistry; 1994 Jun; 33(22):6986-97. PubMed ID: 8204632
[TBL] [Abstract][Full Text] [Related]
29. Structure and properties of clots from fibrinogen Bicêtre II (gamma 308 Asn-->Lys). Increased permeability due to larger pores, thicker fibers, and decreased rigidity.
Marchi R; Loyau S; Anglés-Cano E; Weisel JW
Ann N Y Acad Sci; 2001; 936():125-8. PubMed ID: 11460469
[TBL] [Abstract][Full Text] [Related]
30. Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP).
Etscheid M; Subramaniam S; Lochnit G; Zabczyk M; Undas A; Lang IM; Hanschmann KM; Kanse SM
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3397-3406. PubMed ID: 30076961
[TBL] [Abstract][Full Text] [Related]
31. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.
Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Santos NC; Ariёns RAS
Nanomedicine; 2018 Apr; 14(3):909-918. PubMed ID: 29410160
[TBL] [Abstract][Full Text] [Related]
32. Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.
Westbury SK; Duval C; Philippou H; Brown R; Lee KR; Murden SL; Phillips E; Reilly-Stitt C; Whalley D; Ariëns RA; Mumford AD
Thromb Haemost; 2013 Dec; 110(6):1135-44. PubMed ID: 24048413
[TBL] [Abstract][Full Text] [Related]
33. Comparison of thrombin-catalyzed fibrin polymerization and factor XIIIa-catalyzed cross-linking of fibrin among three recombinant variant fibrinogens, gamma 275C, gamma 275H, and gamma 275A.
Hirota-Kawadobora M; Terasawa F; Suzuki T; Tozuka M; Sano K; Okumura N
J Thromb Haemost; 2004 Aug; 2(8):1359-67. PubMed ID: 15304042
[TBL] [Abstract][Full Text] [Related]
34. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
[TBL] [Abstract][Full Text] [Related]
35. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
36. End-linked homodimers in fibrinogen Osaka VI with a B beta-chain extension lead to fragile clot structure.
Sugo T; Nakamikawa C; Yoshida N; Niwa K; Sameshima M; Mimuro J; Weisel JW; Nagita A; Matsuda M
Blood; 2000 Dec; 96(12):3779-85. PubMed ID: 11090060
[TBL] [Abstract][Full Text] [Related]
37. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
[TBL] [Abstract][Full Text] [Related]
38. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
Terasawa F; Kani S; Hongo M; Okumura N
Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
[TBL] [Abstract][Full Text] [Related]
39. The ultrastructure of fibrinogen-420 and the fibrin-420 clot.
Mosesson MW; DiOrio JP; Hernandez I; Hainfeld JF; Wall JS; Grieninger G
Biophys Chem; 2004 Dec; 112(2-3):209-14. PubMed ID: 15572250
[TBL] [Abstract][Full Text] [Related]
40. Recombinant fibrinogen, gamma275Arg-->Cys, exhibits formation of disulfide bond with cysteine and severely impaired D:D interactions.
Ishikawa S; Hirota-Kawadobora M; Tozuka M; Ishii K; Terasawa F; Okumura N
J Thromb Haemost; 2004 Mar; 2(3):468-75. PubMed ID: 15009465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
